Apr
01

April 2017

EASL (Amsterdam 2017). Exciting to see the series of LOWR abstracts at EASL highlighting the Hepatitis Delta studies with Lonafarnib. SPRI clinical has enjoyed the great partnership with the sites in advancing the understanding of Hepatitis Delta.

Back to Blog